FDA
approval
· 2019-01-25
FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
Summary
FDA approves a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, pertaining to the existing long-acting inject…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for INVEGA SUSTENNA (PALIPERIDONE PALMITATE)